# Medipal

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medipal

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.medipal.co.kr
- Total disclosed funding: $3.8M
- Latest round: Series A (Nov 1, 2023)
- Investors on record: 5

## About

Medipal provides innovative healthcare solutions aimed at enhancing patient care and operational efficiency in medical facilities, with a focus on medical devices and digital health technologies.Medipal focuses on developing and delivering healthcare solutions that improve patient care in medical settings. Founded by Alexander Pang, the company is based in Seoul, South Korea. Medipal has undergone strategic growth, securing KRW 5 billion in Series A funding on November 1, 2023, from investors including Bass Ventures, Insight Equity Partners, and KT Investment, which has contributed to a total amount raised of KRW 5 billion. The company has completed three significant deals to date, solidifying its position in the healthcare market.Medipal Inc. specializes in the development and provision of innovative healthcare solutions targeted at enhancing patient care and operational efficiency within medical facilities. The company’s core product offerings encompass a range of medical devices and digital health solutions designed to streamline patient management and improve clinical outcomes. These products are engineered to address specific challenges in patient monitoring, data management, and therapeutic interventions, thus catering to hospitals, clinics, and healthcare providers globally. Medipal serves a diverse clientele, including healthcare institutions in the Asia-Pacific region, with a growing presence in markets that prioritize advanced medical technologies and patient-centric solutions. The release of their flagship products has positioned Medipal as a pivotal player in the healthcare sector, enabling them to meet the evolving demands of modern healthcare systems.Medipal generates revenue through a structured model that combines direct sales to healthcare providers and strategic partnerships within the medical industry. The company engages in B2B transactions, supplying its products to hospitals and clinics that prioritize quality and innovation in their healthcare offerings. Revenue streams are derived from the sale of proprietary medical devices, which are critical in enhancing patient outcomes, as well as ongoing contracts for digital health solutions that facilitate effective patient monitoring and data analytics. Specific pricing plans associated with these products are tailored to meet the needs of various healthcare facilities, reflecting the value and efficacy of the solutions offered. This strategic approach to revenue generation positions Medipal effectively within the competitive landscape of the healthcare technology market.In November 2023, Medipal raised KRW 5 billion in Series A funding to enhance local medical care services, focusing on improving patient care. The company plans to leverage this funding to develop new products aimed at expanding its offerings and addressing emerging needs in healthcare. Additionally, Medipal is exploring opportunities to enter new markets across the Asia-Pacific region to broaden its geographic reach and customer base.

## Funding rounds

- Series A, Nov 1, 2023, $3.8M — KT Investment, Bass Ventures, Insight Equity Partners
- Seed, Jul 2, 2020 — Merry Year Social Company, Sopoong Ventures

## Investors

- Merry Year Social Company (https://capitalatlas.ai/funds/merry-year-social-company) — Seed
- Sopoong Ventures (https://capitalatlas.ai/funds/sopoong-ventures) — Seed
- KT Investment (https://capitalatlas.ai/funds/kt-investment) — Series A
- Bass Ventures (https://capitalatlas.ai/funds/bass-ventures) — Series A
- Insight Equity Partners (https://capitalatlas.ai/funds/insight-equity-partners) — Series A